CY1125282T1 - Υδροξυλιωση στη θεση 21 των στεροειδων - Google Patents

Υδροξυλιωση στη θεση 21 των στεροειδων

Info

Publication number
CY1125282T1
CY1125282T1 CY20211101095T CY211101095T CY1125282T1 CY 1125282 T1 CY1125282 T1 CY 1125282T1 CY 20211101095 T CY20211101095 T CY 20211101095T CY 211101095 T CY211101095 T CY 211101095T CY 1125282 T1 CY1125282 T1 CY 1125282T1
Authority
CY
Cyprus
Prior art keywords
hydroxylation
steroid
steroids
relates
cells
Prior art date
Application number
CY20211101095T
Other languages
English (en)
Inventor
Claus Lattemann
Thomas Stillger
Bernd Janocha
Hans-Falk Rasser
Sebastian Rissom
Simone ANDERKO
Rita Bernhardt
Frank Hannemann
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of CY1125282T1 publication Critical patent/CY1125282T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C12N9/0038—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6) with a heme protein as acceptor (1.6.2)
    • C12N9/0042—NADPH-cytochrome P450 reductase (1.6.2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • C12N9/0087—Steroid 21-monooxygenase (1.14.99.10)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0095—Oxidoreductases (1.) acting on iron-sulfur proteins as donor (1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/14—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/99—Miscellaneous (1.14.99)
    • C12Y114/9901—Steroid 21-monooxygenase (1.14.99.10), i.e. steroid cytochrome P450 21-hydroxylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y118/00—Oxidoreductases acting on iron-sulfur proteins as donors (1.18)
    • C12Y118/01—Oxidoreductases acting on iron-sulfur proteins as donors (1.18) with NAD+ or NADP+ as acceptor (1.18.1)
    • C12Y118/01002—Ferredoxin-NADP+ reductase (1.18.1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y118/00—Oxidoreductases acting on iron-sulfur proteins as donors (1.18)
    • C12Y118/01—Oxidoreductases acting on iron-sulfur proteins as donors (1.18) with NAD+ or NADP+ as acceptor (1.18.1)
    • C12Y118/01006—Adrenodoxin-NADP+ reductase (1.18.1.6)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Σε γενικές γραμμές, η παρούσα εφεύρεση αναφέρεται στον τομέα της υδροξυλίωσης στεροειδών. Πιο συγκεκριμένα, η παρούσα εφεύρεση αναφέρεται σε μια μέθοδο υδροξυλίωσης στη θέση 21 των στεροειδών σε κύτταρα. Αναφέρεται, επίσης, σε κύτταρα που εκφράζουν ένα στεροειδές ένζυμο υδροξυλίωσης στη θέση 21 ή μια στεροειδή 21-υδροξυλάση, σε φορείς έκφρασης που περιλαμβάνουν ένα νουκλεϊκό οξύ που κωδικοποιεί μια στεροειδή 21-υδροξυλάση και σε ένα κιτ για την πραγματοποίηση της μεθόδου υδροξυλίωσης στη θέση 21 των στεροειδών σε κύτταρα.
CY20211101095T 2014-10-30 2021-12-14 Υδροξυλιωση στη θεση 21 των στεροειδων CY1125282T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306740.3A EP3015550A1 (en) 2014-10-30 2014-10-30 21-Hydroxylation of steroids
PCT/EP2015/075096 WO2016066738A1 (en) 2014-10-30 2015-10-29 21-hydroxylation of steroids

Publications (1)

Publication Number Publication Date
CY1125282T1 true CY1125282T1 (el) 2023-03-24

Family

ID=51932297

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211101095T CY1125282T1 (el) 2014-10-30 2021-12-14 Υδροξυλιωση στη θεση 21 των στεροειδων

Country Status (13)

Country Link
US (3) US10385376B2 (el)
EP (3) EP3015550A1 (el)
JP (3) JP6856528B2 (el)
CN (2) CN108138215B (el)
CA (1) CA2966067C (el)
CY (1) CY1125282T1 (el)
DK (1) DK3212800T3 (el)
ES (1) ES2898465T3 (el)
HU (1) HUE056495T2 (el)
IL (3) IL251978B (el)
SG (2) SG11201703444SA (el)
TW (3) TWI836530B (el)
WO (1) WO2016066738A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110229838B (zh) * 2019-05-28 2021-01-08 浙江理工大学 一种生物转化类固醇类化合物获取羟基化化合物的方法
CN114410727B (zh) * 2022-01-25 2023-09-19 山东诺明康药物研究院有限公司 一种克拉考特酮的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577965B2 (en) 1985-10-29 1988-10-06 Hooi Heng Lim Nappy change bag
GB9615032D0 (en) * 1996-07-17 1996-09-04 Univ Dundee Enzyme system
JP3344618B2 (ja) * 1997-06-20 2002-11-11 株式会社エイチ・エス・ピー研究所 シャペロン発現プラスミド
JP4249832B2 (ja) 1998-12-28 2009-04-08 タカラバイオ株式会社 トリガーファクター発現プラスミド
KR20050028279A (ko) * 2003-09-18 2005-03-22 안태호 열 충격 단백질 유전자들과의 동시발현에 의한 재조합시토크롬 p450 효소들의 단백질 발현 및 활성 증가

Also Published As

Publication number Publication date
US11608514B2 (en) 2023-03-21
IL251978A0 (en) 2017-06-29
US10385376B2 (en) 2019-08-20
IL285700A (en) 2021-09-30
JP7364611B2 (ja) 2023-10-18
SG11201703444SA (en) 2017-05-30
ES2898465T3 (es) 2022-03-07
JP2021097709A (ja) 2021-07-01
IL275237B (en) 2021-09-30
CN114540453A (zh) 2022-05-27
US20220228189A1 (en) 2022-07-21
TWI816043B (zh) 2023-09-21
JP2017532057A (ja) 2017-11-02
CN108138215A (zh) 2018-06-08
DK3212800T3 (da) 2021-12-06
TW202300653A (zh) 2023-01-01
IL275237A (en) 2020-07-30
WO2016066738A1 (en) 2016-05-06
EP3957739A1 (en) 2022-02-23
EP3015550A1 (en) 2016-05-04
SG10201906501YA (en) 2019-09-27
JP6856528B2 (ja) 2021-04-07
TWI836530B (zh) 2024-03-21
IL285700B1 (en) 2023-01-01
JP2024001138A (ja) 2024-01-09
CN108138215B (zh) 2022-01-25
US20190352690A1 (en) 2019-11-21
IL285700B2 (en) 2023-05-01
EP3212800B1 (en) 2021-09-15
TWI701336B (zh) 2020-08-11
US20170321241A1 (en) 2017-11-09
TW201625795A (zh) 2016-07-16
CA2966067C (en) 2024-01-02
IL251978B (en) 2020-06-30
EP3212800A1 (en) 2017-09-06
CA2966067A1 (en) 2016-05-06
TW202041676A (zh) 2020-11-16
HUE056495T2 (hu) 2022-02-28
US11965199B2 (en) 2024-04-23

Similar Documents

Publication Publication Date Title
ZA202107931B (en) Anti-tau antibodies and methods of use
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
CY1124131T1 (el) Συζευγματα αντι-ρτκ7 αντισωματος-φαρμακου
SA518391159B1 (ar) مترافقات الألفة- قليلة النيوكليوتيد واستخداماتها
MX2024000300A (es) Anticuerpos antitau y metodos de uso.
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
TR2021016542A2 (tr) Plazma bazlı filmler ve bunları üretme ve kullanma usulleri.
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
MY193661A (en) Anti-tim3 antibodies and methods of use
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
PH12016501435A1 (en) Anti-jagged1 antibodies and methods of use
EP3161127A4 (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
WO2018106776A3 (en) Anti-tau antibodies and methods of their use
WO2018081648A8 (en) ANTI-MIC ANTIBODIES AND METHODS OF USE
MX2016015162A (es) Anticuerpos anti - gpc3 e inmunoconjugados.
MY183188A (en) Non-human animals having a humanized b-cell activating factor gene
GB2540702A (en) Nucleic acid processing of a nucleic acid fragment with a triazole linkage
CY1125282T1 (el) Υδροξυλιωση στη θεση 21 των στεροειδων
EP3493836A4 (en) TRANSFECTION OF DENDRITIC CELLS AND RELATED METHODS
MX2021000899A (es) Composiciones y metodos para determinar el pronostico de cancer de endometrio.
EA201400940A1 (ru) Способ получения медетомидина
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
IL270823A (en) Insulating factors, kits for them, and methods for using insulating factors and kits for them
EP3685661A4 (en) PROCESS FOR DEVELOPMENT OF AN ORGAN LACKING A SPECIFIC FUNCTIONAL CELL